Form 4 for NMRA Neumora Therapeutics, Inc.
Accepted 2026-08-19 19:17:14 ET · period of report 2026-08-17 · accession 0001610717-26-000362 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-19 19:17 | 2026-08-17+ | NMRA | Aurora Daljit Singh | See Remarks | M - OptEx | $0.72 | +122.8K | 79.8K | New | +$88.4K |
| DM | 2026-08-19 19:17 | 2026-08-17+ | NMRA | Aurora Daljit Singh | See Remarks | S - Sale+OE | $1.55 | -156.9K | 48.8K | -76% | -$242.5K |
| DMI | 2026-08-19 19:17 | 2026-08-17+ | NMRA | Aurora Daljit Singh | See Remarks | M - OptEx | $0.72 | +120.9K | 30.9K | New | +$87.1K |
| DMI | 2026-08-19 19:17 | 2026-08-17+ | NMRA | Aurora Daljit Singh | See Remarks | S - Sale+OE | $1.56 | -120.9K | 0 | -100% | -$189.2K |
| DM | 2026-08-19 19:17 | 2026-08-17+ | NMRA | Aurora Daljit Singh | See Remarks | M - OptEx | $0.00 | -122.8K | 177.3K | -41% | $0 |
| DMI | 2026-08-19 19:17 | 2026-08-17+ | NMRA | Aurora Daljit Singh | See Remarks | M - OptEx | $0.00 | -120.9K | 45.0K | -73% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-17 | M | A | 40,890 | $0.72 | 123,660 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-17 | M | A | 15,355 | $0.72 | 139,015 | D | — | — | |
| 3 | Common | Common Stock | 2026-08-17 | M | A | 1,424 | $0.72 | 140,439 | D | — | — | |
| 4 | Common | Common Stock | 2026-08-17 | M | A | 1 | $0.72 | 140,440 | D | — | — | |
| 5 | Common | Common Stock | 2026-08-17 | S | D | 57,670 | $1.51 | 82,770 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $1.46 to $1.555, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2026-08-17 | S | D | 34,020 | $1.49 | 48,750 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $1.46 to $1.5277, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2026-08-17 | M | A | 25,279 | $0.72 | 25,279 | I See footnote | — | — | (F3) Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. |
| 8 | Common | Common Stock | 2026-08-17 | M | A | 29,737 | $0.72 | 55,016 | I See footnote | — | — | (F3) Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. |
| 9 | Common | Common Stock | 2026-08-17 | S | D | 55,016 | $1.50 | 0 | I See footnote | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $1.46 to $1.555, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F3) Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. |
| 10 | Common | Common Stock | 2026-08-18 | M | A | 34,162 | $0.72 | 82,912 | D | — | — | |
| 11 | Common | Common Stock | 2026-08-18 | S | D | 34,162 | $1.58 | 48,750 | D | — | — | (F9) This transaction was executed in multiple trades at prices ranging from $1.49 to $1.645, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 12 | Common | Common Stock | 2026-08-18 | M | A | 34,987 | $0.72 | 34,987 | I See footnote | — | — | (F3) Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. |
| 13 | Common | Common Stock | 2026-08-18 | S | D | 34,987 | $1.59 | 0 | I See footnote | — | — | (F10) This transaction was executed in multiple trades at prices ranging from $1.48 to $1.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F3) Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. |
| 14 | Common | Common Stock | 2026-08-19 | M | A | 13,268 | $0.72 | 62,018 | D | — | — | |
| 15 | Common | Common Stock | 2026-08-19 | M | A | 17,732 | $0.72 | 79,750 | D | — | — | |
| 16 | Common | Common Stock | 2026-08-19 | S | D | 31,000 | $1.65 | 48,750 | D | — | — | (F11) This transaction was executed in multiple trades at prices ranging from $1.62 to $1.6995, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 17 | Common | Common Stock | 2026-08-19 | M | A | 30,918 | $0.72 | 30,918 | I See footnote | — | — | (F3) Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. |
| 18 | Common | Common Stock | 2026-08-19 | S | D | 30,918 | $1.65 | 0 | I See footnote | — | — | (F12) This transaction was executed in multiple trades at prices ranging from $1.62 to $1.7006, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F3) Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. |
| 19 | Derivative | Stock Option (Right to Buy) | 2026-08-17 | M | D | 40,890 | $0.00 | 0 | D | $0.72 · — to 2031-09-20 | 40,890 Common Stock | (F5) The stock option is fully vested and exercisable. |
| 20 | Derivative | Stock Option (Right to Buy) | 2026-08-17 | M | D | 15,355 | $0.00 | 192,546 | D | $0.72 · — to 2033-01-19 | 15,355 Common Stock | (F6) 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 21 | Derivative | Stock Option (Right to Buy) | 2026-08-17 | M | D | 1,424 | $0.00 | 70,797 | D | $0.72 · — to 2033-06-23 | 1,424 Common Stock | (F7) 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 22 | Derivative | Stock Option (Right to Buy) | 2026-08-17 | M | D | 1 | $0.00 | 999,999 | D | $0.72 · — to 2035-02-13 | 1 Common Stock | (F8) 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 23 | Derivative | Stock Option (Right to Buy) | 2026-08-17 | M | D | 25,279 | $0.00 | 110,931 | I See footnote | $0.72 · — to 2033-01-19 | 25,279 Common Stock | (F5) The stock option is fully vested and exercisable. (F3) Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. |
| 24 | Derivative | Stock Option (Right to Buy) | 2026-08-17 | M | D | 29,737 | $0.00 | 0 | I See footnote | $0.72 · — to 2033-06-23 | 29,737 Common Stock | (F5) The stock option is fully vested and exercisable. (F3) Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. |
| 25 | Derivative | Stock Option (Right to Buy) | 2026-08-18 | M | D | 34,162 | $0.00 | 36,635 | D | $0.72 · — to 2033-06-23 | 34,162 Common Stock | (F7) 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 26 | Derivative | Stock Option (Right to Buy) | 2026-08-18 | M | D | 34,987 | $0.00 | 75,944 | I See footnote | $0.72 · — to 2033-01-19 | 34,987 Common Stock | (F5) The stock option is fully vested and exercisable. (F3) Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. |
| 27 | Derivative | Stock Option (Right to Buy) | 2026-08-19 | M | D | 13,268 | $0.00 | 23,367 | D | $0.72 · — to 2033-06-23 | 13,268 Common Stock | (F7) 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 28 | Derivative | Stock Option (Right to Buy) | 2026-08-19 | M | D | 17,732 | $0.00 | 177,268 | D | $0.72 · — to 2034-02-14 | 17,732 Common Stock | (F13) 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 29 | Derivative | Stock Option (Right to Buy) | 2026-08-19 | M | D | 30,918 | $0.00 | 45,026 | I See footnote | $0.72 · — to 2033-01-19 | 30,918 Common Stock | (F5) The stock option is fully vested and exercisable. (F3) Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. |